Cited time in webofscience Cited time in scopus

Olfactory marker protein regulation of glucagon secretion in hyperglycemia

Title
Olfactory marker protein regulation of glucagon secretion in hyperglycemia
Author(s)
Oh, Ju HunHan, Ye EonBao, Ya RuKang, Chan WooKoo, JaeHyungKu, Cheol RyongCho, Yoon HeeLee, Eun Jig
Issued Date
2022-09
Citation
Experimental and Molecular Medicine, v.54, no.9, pp.1502 - 1510
Type
Article
Keywords
PANCREATIC ALPHA-CELLSGLUCOSEMOUSECALCIUMSTIMULATIONCHANNELS
ISSN
1226-3613
Abstract
Glucose metabolism: Smell receptor implicated in regulation of blood sugar The same signaling pathway that controls smell perception in the nose is involved in regulating the release of a pancreatic hormone needed when blood sugar levels are high. The olfactory marker protein (OMP) is a marker of chemical signaling mediated by olfactory receptors, which are located not only in the nose but throughout the body. A research team led by Eun Jig Lee and Yoon Hee Cho from Yonsei University College of Medicine, Seoul, South Korea, showed that human and mouse pancreatic alpha-cells, endocrine cells that secrete the peptide hormone glucagon to increase glucose levels in the bloodstream, express OMP. Blocking OMPactivity impairs glucagon response pathways. Therapeutics directed at olfactory receptor signaling in the pancreas could therefore help reduce excessive glucagon activity associated with diseases such as type 2 diabetes. The olfactory marker protein (OMP), which is also expressed in nonolfactory tissues, plays a role in regulating the kinetics and termination of olfactory transduction. Thus, we hypothesized that OMP may play a similar role in modulating the secretion of hormones involved in Ca2+ and cAMP signaling, such as glucagon. In the present study, we confirmed nonolfactory alpha-cell-specific OMP expression in human and mouse pancreatic islets as well as in the murine alpha-cell line alpha TC1.9. Glucagon and OMP expression increased under hyperglycemic conditions. Omp knockdown in hyperglycemic alpha TC1.9 cells using small-interfering RNA (siRNA) reduced the responses to glucagon release and the related signaling pathways compared with the si-negative control. The OMPlox/lox;GCG(cre/w) mice expressed basal glucagon levels similar to those in the wild-type OMPlox/lox mice but showed resistance against streptozotocin-induced hyperglycemia. The ectopic olfactory signaling events in pancreatic alpha-cells suggest that olfactory receptor pathways could be therapeutic targets for reducing excessive glucagon levels.
URI
http://hdl.handle.net/20.500.11750/16918
DOI
10.1038/s12276-022-00843-8
Publisher
생화학분자생물학회
Related Researcher
  • 구재형 Koo, JaeHyung
  • Research Interests 장내미생물/감염균 유래 대사체를 통한 신경염증; 알츠하이머병; 우울증; 당뇨/비만; 대사체/수용체 상호작용에 의한 대사연구
Files in This Item:

There are no files associated with this item.

Appears in Collections:
Department of New Biology Brain-Immune Axis Laboratory 1. Journal Articles

qrcode

  • twitter
  • facebook
  • mendeley

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE